Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Targets for Cancer IO: 2024 Deep Dive - A Deep Dive into Personalized Vaccines

Live Webinar 3: Tuesday, July 9, 2024, from 12–2 p.m. EDT

Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future.

2024 Glyco-Immunology Webinar Series

Presented by SITC and the Society for Glycobiology, this FREE webinar series will address the impact of glycobiology on immune regulation, anti-tumor immunity, and immune resistance. Develop more effective cancer immunotherapies by applying principles of glyco-immunology.

A Global Webinar Series - Cell Therapy Administration: Increasing Access to IO

Live Webinar 2: Wednesday, July 10, 2024 - 8:30–10 a.m. EDT

These free digital events provide a forum for international physicians to discuss overcoming barriers in administering local immunotherapy treatment.

Nominate an Emerging Leader in IO

Submit Nominations by July 15

The Steven A. Rosenberg Scholars Award is one of the society's most prestigious opportunities for early career scientists. If you know a deserving emerging leader, nominate them by July 15, 2024.

Computational Immuno-oncology Webinar - Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncology

Live Webinar 4: Tuesday, July 30, 2024 - 1:30–2:30 p.m. EDT

Advance your training in computational immuno-oncology and stay abreast of the latest technologies. Register for FREE!

Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

Wednesday, Sept. 11 |1–5 p.m. ET 
Virtual – Zoom

Program addresses how to identify and manage CAR T -associated secondary malignancies. FREE for healthcare professionals, students, patients and patient advocates.

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 |11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.